°ÇÃà ¼Ò½Ä

Á¦¸ñ [±¹ÅäºÎ]°Ç¼³Çõ½Å ¼±µµÇÒ À¯¸Á±â¾÷ 100°³»ç ¼±Á¤¡¤Áö¿ø
ÀÛ¼ºÀÏÀÚ 2020-10-26

±¹Åä±³ÅëºÎ(Àå°ü ±èÇö¹Ì)´Â ¼ºÀåÀáÀç·Â°ú ±â¼ú·ÂÀ» º¸À¯ÇÑ °Ç¼³¾÷°è Áß¼Ò±â¾÷À» ´ë»óÀ¸·Î °Ç¼³Çõ½Å ¼±µµ±â¾÷ 100°³»ç¸¦ ¹ß±¼ÇÏ°í ±â¼ú°³¹ß ¹× ±¹³»¡¤ÇؿܽÃÀå °³Ã´ µî Àü¹æÀ§·Î Áö¿øÇÑ´Ù°í ¹àÇû´Ù.

°Ç¼³Çõ½Å ¼±µµ±â¾÷À¸·Î ¼±Á¤µÈ 100´ë ±â¾÷Àº ¡®ÀÛÁö¸¸ °­ÇÑ¡¯ ±â¾÷À¸·Î ¼ºÀåÇÏ°í °Ç¼³»ê¾÷ ¹ßÀüÀ» À̲ø¾î °¥ °Ç¼³Çõ½ÅÀÇ ¾ÆÀÌÄÜÀÌ µÉ °ÍÀ¸·Î ±â´ëµÈ´Ù.

±¹Åä±³ÅëºÎ´Â 10¿ù 26ÀϺÎÅÍ 3ÁÖ°£(10.26 ~ 11.15) Á߼ҰǼ³±â¾÷µéÀÇ ½ÅûÀ» ¹Þ°í 「°Ç¼³Çõ½Å¼±µµ±â¾÷ ¼±Á¤À§¿øȸ」 Æò°¡¸¦ °ÅÃÄ ÃÖÁ¾ÀûÀ¸·Î 11¿ù¸» ´ë»ó±â¾÷À» ¼±Á¤ÇÑ´Ù.

「°Ç¼³Çõ½Å¼±µµ±â¾÷ ¼±Á¤À§¿øȸ」´Â À̹ø¿¡ »õ·ÎÀÌ ÃßÁøÇÏ´Â 100´ë °Ç¼³Çõ½Å Á߼ҰǼ³±â¾÷ ¼±Á¤À» À§ÇØ ÃÖÃÊ·Î ±¸¼ºµÇ¸ç, »ê¾÷°è, °ø°ø¹ßÁÖ±â°ü, ¿¬±¸±â°ü µîÀÌ Âü¿©ÇÏ°Ô µÈ´Ù.

100´ë °Ç¼³Çõ½Å ¼±µµ±â¾÷ÀÇ ¼±Á¤°èȹÀº ´ÙÀ½°ú °°´Ù.

(¼±Á¤ºÐ¾ß) 100´ë Á߼ҰǼ³±â¾÷ ¼±Á¤Àº Á¾ÇÕ¡¤Àü¹® °Ç¼³¾÷ ±¸ºÐ¾øÀÌ ¸ðµç Á߼ҰǼ³±â¾÷À» ´ë»óÀ¸·Î ÀÌ·ç¾îÁø´Ù. ¶ÇÇÑ, ¨ç±â¼ú°³¹ß(30%), ¨è½ÃÀåÁøÃâ(60%), ¨é±â¼ú°³¹ß¡¤½ÃÀåÁøÃâ(10%)·Î ºÐ·ùÇÏ¿© ºÐ¾ßº°·Î °æÀï·ÂÀ» °®Ãá °Ç¼³Çõ½Å ¼±µµ±â¾÷À» ¼±Á¤ÇØ ³ª°£´Ù´Â °èȹÀÌ´Ù.

(¼±Á¤´ë»ó) ¼±Á¤ ´ë»óÀº ¼ºÀåÀáÀç·ÂÀ» º¸À¯ÇÑ ±â¾÷À¸·Î ¸ÅÃâ½ÇÀû ¹× ±â¼úÀη °í¿ëºñÀ²ÀÌ Áö¼Ó Áõ°¡ÇÏ°í, ¹Ì·¡ ÅõÀÚ°èȹµµ °®Ãá ±â¾÷À» ´ë»óÀ¸·Î ÇÑ´Ù. ¶ÇÇÑ, 2³â ÀÌ»ó ½ÇÀûÀÌ ¾ø´Â °æ¿ì, »ç¸Á»ç°í ¹ß»ý µîÀ¸·Î ÇàÁ¤Ã³ºÐÀ» ¹ÞÀº °æ¿ì, ºÎµµ¡¤È¸»ý¡¤¿öÅ©¾Æ¿ô µî ºÎ½Ç±â¾÷¿¡ ÇØ´çÇÏ´Â °æ¿ì¿¡´Â ¼±Á¤´ë»ó¿¡¼­ Á¦¿ÜµÈ´Ù.

°¢ ºÎ¹®º°·Î ¨ç½ÃÀåÁøÃâ(±¹³») ±âÁØÀº Á¾ÇհǼ³¾÷ÀÇ °æ¿ì Á÷Á¢½Ã°ø´É·Â, Àü¹®°Ç¼³¾÷Àº °ø»ç°ü¸®´É·ÂÀ» Áß½ÉÀ¸·Î Æò°¡ÇÏ¿© ¼±Á¤ÇÑ´Ù. ¶ÇÇÑ, ¨è½ÃÀåÁøÃâ(ÇØ¿Ü)´Â ÇØ¿ÜÁøÃâ °èȹÀÇ Å¸´ç¼º¡¤±¸Ã¼¼ºÀ» Áß½ÉÀ¸·Î, ¨é±â¼ú°³¹ßÀº ±â¼ú ±¸Çö °¡´É¼ºÀ» Áß½ÉÀ¸·Î Æò°¡¡¤¼±Á¤ÇÑ´Ù.

100´ë °Ç¼³Çõ½Å ¼±µµ±â¾÷À¸·Î ¼±Á¤µÈ ±â¾÷À» ´ë»óÀ¸·Î ±â¾÷ÀÇ Æ¯¼º°ú ¼ö¿ä¸¦ °í·ÁÇÑ ¸ÂÃãÇü Áö¿øÀ» ÃßÁøÇÒ °èȹÀÌ´Ù.

(°øÅëÁö¿ø) ±¹ÅäºÎ´Â ¹æ¾È ¸¶·ÃÀ» À§ÇØ Á߼ҰǼ³±â¾÷ 140°³¸¦ ´ë»óÀ¸·Î ¼ö¿ä¸¦ Á¶»ç(¡¯20.8~9¿ù, ±¹Å俬±¸¿ø)ÇÏ¿´À¸¸ç, À̸¦ ±âÃÊ·Î º¸ÁõºÎ´ã¿ÏÈ­(¼ö¼ö·á 10%¡é), Àú¸®ÀÚ±Ý ´ëÃâ È®´ë(20%¡è) µî ´Ü±â°£¿¡ »ç¾÷ ¿©°ÇÀ» °³¼±½Ãų ¼ö ÀÖ´Â ´Ù¾çÇÑ ¹æ¾ÈÀ» Áö¿øÇÑ´Ù.

(ºÐ¾ßº°Áö¿ø) ¶ÇÇÑ, ºÐ¾ßº° °æÀï·ÂÀ» °®Ãâ ¼ö ÀÖµµ·Ï ƯÁ¤ ºÐ¾ß¿¡ ƯȭµÈ Áö¿øµµ ÃßÁøÇÑ´Ù.

¨ç½ÃÀåÁøÃâ(±¹³») ºÐ¾ßÀÇ °æ¿ì »óÈ£Çù·ÂÆò°¡ °¡Á¡(3Á¡), °í¿ëÆò°¡ °¡Á¡(0.5Á¡), ÀÎÁõÁ¦(KISCON ±â¾÷Á¤º¸ °ø°³)* µîÀ» ÅëÇØ Áö¿øÇÏ°í, ¨è½ÃÀåÁøÃâ(ÇØ¿Ü) ºÐ¾ß´Â Ÿ´ç¼º¡¤»ç¾÷¼º ºÐ¼®(KIND)** ¹× ½ÃÀ尳ô Áö¿ø(ÇؿܰǼ³Çùȸ) ±×¸®°í ÄÁ¼³ÆÃ(ÇؿܰǼ³Çùȸ¡¤·ÎÆß) µîÀ» Áö¿øÇÑ´Ù.

* 100´ë ±â¾÷¿¡ ´ëÇÑ È«º¸¡¤Àνݳ¼± µîÀ» À§ÇØ ÀÎÁõ¼­¡¤ÀÎÁõ¸¶Å©¸¦ ºÎ¿©
** ÇؿܽÃÀå ÁøÃâ½Ã »ç¾÷ÀÇ ÇöÁö»çÁ¤»ó ÀûÇÕ ¿©ºÎ, ¼öÀÍâÃâ °¡´É¼º µî °ËÅä


¶ÇÇÑ ¨é±â¼ú°³¹ßÀÇ °æ¿ì â¾÷ »ýÅ°è Ç÷§Æû Á¦°øÀ» À§ÇÑ ¡®½º¸¶Æ® °Ç¼³Áö¿ø¼¾ÅÍ¡¯* ÀÔÁÖÁö¿ø(¡¯21³â ¸»), Çõ½Å±â¼ú ¼ö¿äó Á¦°øÀ» À§ÇÑ ¡®¼ö¿ä±â¹Ý ±â¼ú»ç¾÷È­ Áö¿ø»ç¾÷¡¯** ¼±Á¤ ¿ì´ë µîÀ» ÅëÇØ Áö¿øÇÑ´Ù.

* ±â¼ú Çõ½Å ±â¾÷ÀÌ ÇÑ °ø°£¿¡ ¸ð¿© ±â¼úÀ» °³¹ß¡¤°øÀ¯ÇÒ ¼ö ÀÖµµ·Ï Áö¿ø
** ±â¾÷¼ö¿ä¿¡ µû¸¥ ±â¼ú °³¹ßÀ» Áö¿ø, »ç¾÷È­½Ã ¾Ö·Î»çÇ× ÇØ°áµµ Áö¿ø


100´ë ±â¾÷ ¼±Á¤°èȹ ¹× Áö¿ø¹æ¾È°ú °ü·ÃµÈ ÀÚ¼¼ÇÑ ³»¿ëÀº ±¹Å俬±¸¿ø(www.krihs.re.kr), ´ëÇѰǼ³Çùȸ(www.cak.or.kr), ´ëÇÑÀü¹®°Ç¼³Çùȸ(www.kosca.or.kr) ´©¸®ÁýÀ» ÅëÇØ È®ÀÎ °¡´ÉÇÏ´Ù.


Ãâó : http://www.molit.go.kr/USR/NEWS/m_71/dtl.jsp?lcmspage=1&id=95084652

À̸§ ºñ¹Ð¹øÈ£



* ÇÑ±Û 1000ÀÚ ±îÁö¸¸ ÀԷ°¡´É : ÀÚ
Unsummogs Breast Cancer Trials Committee 1987 Adjuvant tamoxifen in the management of operable breast cancer the Scottish Trial, Scottish Cancer Trials Office MRC, Edinburgh <a href=http://clomid.mom/>clomid and nolvadex for pct</a> 2022-11-17 21:25:55
Dredymn <a href=http://clevitras.monster>cout levitra belgique</a> Furthermore, when prices diverge from fundamental value by such wide margins, the misallocation of resources can be quite big 2022-12-15 09:39:41

>ÀÌ¿ë¾à°ü >°³ÀÎÁ¤º¸ Ãë±Þ¹æħ >¿À½Ã´Â ±æ >°ü¸®ÀÚ


  • »óÈ£ °Ç¿µÁ¾ÇÕ°³¹ß¢ß´ëÇ¥ÀÚ ±è¿µÈ£»ó´ã¹®ÀÇ 02-3437-6733À̸ÞÀÏÁÖ¼Ò kunyoung09@naver.com
  • ÁÖ¼Ò ¼­¿ï½Ã ¼ÛÆı¸ ¼ÛÆÄ´ë·Î167, Bµ¿ 3Ãþ 318È£ (¹®Á¤µ¿, ¹®Á¤¿ªÅ׶óŸ¿ö) »ç¾÷ÀÚµî·Ï¹øÈ£ 290-88-00805 (»ç¾÷ÀÚÁ¤º¸È®ÀÎ)
  • ÀνºÅ¸±×·¥
  • COPYRIGHT¨Ï KUNYOUNG Construction Corp. All Rights Reserved